Together we will beat cancer

Donate

Cancer killer combination could make cells more sensitive to chemo

How our researchers in Manchester are helping develop ways to make chemotherapy kinder and more effective.

Read More

Many hands make light work – the evolution of clinical trials

For International Clinical Trials Day 2015 we look at how trials have changed – from the first recorded trial to today’s modern cancer clinical trials.

Read More

‘Johns Hopkins’ cancer update emails are a hoax

Hoax emails about cancer risks and treatments are misleading and confusing, so don’t pass them on. Here are the facts behind the claims.

Read More

Our milestones: A recipe for success – the birth of combination chemotherapy

This entry is part 21 of 30 in the series Our milestones

In the latest Our Milestones series post, we look at the role we played in the advent of a 1970s cancer treatment revolution: combination chemotherapy.

Read More

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic ‘patchwork’ underlying ovarian tumours, which will lead to more effective treatments in the future.

Read More

The cheek of it – how you could help beat blood cancer

Find out about blood stem cell donation, how you could get involved and even help save someone’s life

Read More

Pushing ‘unstable’ pancreatic cancers over the edge

We look at fascinating new research from our scientists showing that pancreatic cancer can be split into four different types.

Read More

Raising awareness of cancer clinical trials

We feature three personal stories about cancer clinical trials, showing the vital role they play in developing news ways to treat cancer.

Read More

Improving the gold standard for brain tumours

We explore new research from our scientists testing a modified version of a brain cancer drug that could help overcome resistance to treatment.

Read More

The Enemy Within – 50 years of fighting cancer

We look back on the last 50 years of cancer research, where we were, what we’ve achieved and what’s still left to do.

Read More